Access cutting-edge malignant glioma treatment through this clinical trial at a research site in Edison. Study-provided care at no cost to qualified participants.
Access malignant glioma specialists in Edison at no cost
This study follows strict safety protocols and ethical guidelines
All study-related malignant glioma treatment provided free
An open label, non-randomized study in pediatric patients with advanced high-grade gliomas and other solid tumors. The study will be performed in two phases: a dose escalation phase in up to 18 patients following a standard "3+3" design to establish dose-limiting toxicity (DLT) and a "safe" dose of LAM561 followed by an expanded safety cohort of up to 10 patients treated at the Maximum Tolerated Dose (MTD). If the MTD is well tolerated in the expanded safety cohort, that dose becomes the Recomm
Sponsor: Laminar Pharmaceuticals
Check if you qualify for this malignant glioma clinical trial in Edison, NJ
If you're searching for malignant glioma treatment options in Edison, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Edison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.